ReviewPharmaceuticals (Basel, Switzerland)2022

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors.

Artem Ovchinnikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.